Skip to main content
CORESTEMCHEMON Inc. logo

CORESTEMCHEMON Inc. — Investor Relations & Filings

Ticker · 166480 ISIN · KR7166480004 KO Professional, scientific and technical activities
Open in API
Filings indexed 274 across all filing types
Latest filing 2020-07-24 Legal Proceedings Report
Country KR South Korea
Listing KO 166480

About CORESTEMCHEMON Inc.

https://www.corestemchemon.com/eng/main…

CORESTEMCHEMON Inc. is a biotechnology company operating through two main divisions: a biopharmaceutical unit and a non-clinical Contract Research Organization (CRO) unit. The biopharmaceutical division is dedicated to the research and development of new drugs based on stem cell therapy technology. Its clinical pipeline primarily targets neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS), cerebellar ataxia, and multiple sclerosis, as well as autoimmune diseases like systemic lupus erythematosus (SLE) and fibrosis. The non-clinical CRO division provides comprehensive preclinical services, conducting essential toxicity and efficacy evaluations for pharmaceuticals, biopharmaceuticals, cosmetics, and medical devices to support regulatory approval processes.

Recent filings

Filing Released Lang Actions
투자판단관련주요경영사항(줄기세포 치료제인 뉴로나타-알주의 미국 FDA 3상 임상시험계획 승인(Remove Clincal Hold))
Legal Proceedings Report Classification · 1% confidence The document is a regulatory filing from a Korean company (Corestem) regarding a material business event: the FDA's approval to remove a clinical hold on their Phase 3 clinical trial. This is a specific regulatory disclosure of a material event, which does not fit into financial reporting categories like 10-K or IR, nor is it a simple report announcement. It falls under the general regulatory filing category for material corporate events.
2020-07-24 Korean
증권발행결과(자율공시)(제1회차 CB)
Capital/Financing Update Classification · 1% confidence The document is a regulatory filing from Corestem regarding the results of a securities issuance (specifically a convertible bond). It details the issuance amount, payment date, and nature of the securities. This falls under the category of capital and financing updates as it reports on the completion of a financing activity.
2020-06-26 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 1% confidence The document is a formal 'Major Report' (주요사항보고서) filed with the Financial Supervisory Service and Korea Exchange regarding the issuance of convertible bonds (전환사채권 발행결정). It details the terms of the issuance, including interest rates, conversion prices, call/put options, and a list of investors. This falls under the category of capital and financing updates.
2020-06-25 Korean
[기재정정]분기보고서 (2020.03)
Interim / Quarterly Report Classification · 1% confidence The document is a 'Quarterly Report' (분기보고서) for the first quarter of 2020, filed by Corestem Inc. It contains detailed financial statements, business descriptions, and management information. Although it includes a 'Correction Report' (정정신고) header, the core content is the comprehensive quarterly financial report itself, which fits the definition of an Interim/Quarterly Report (IR). Q1 2020
2020-06-18 Korean
분기보고서 (2020.03)
Interim / Quarterly Report Classification · 1% confidence The document is a 'Quarterly Report' (분기보고서) for Corestem Inc. for the period of January 1, 2020, to March 31, 2020. It contains detailed financial information, business descriptions, and management disclosures, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2020
2020-05-14 Korean
사업보고서 (2019.12)
Audit Report / Information Classification · 1% confidence The document is a 'Consolidated Audit Report' (연결감사보고서) for Corestem Inc. for the fiscal year ending December 31, 2019. It includes the independent auditor's report, consolidated financial statements (balance sheet, income statement, statement of changes in equity, cash flow statement), and detailed notes. Since it contains comprehensive financial statements for a specific period (full year) and is an audit report rather than the company's own management-authored Annual Report (10-K), it falls under the category of Audit Report/Information. FY 2019
2020-03-30 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.